Brinter, a Turku, Finland-based bioprinting startup, closed a €1.2M seed funding round.
The round was led by early-stage VC Innovestor.
The company will use the capital to further expand its operations internationally in Europe and the US.
Founded in 2020 via partial demerger in Turku, Finland, and led by CEO Tomi Kalpio, Brinter is a modular multi-material bioprinting platform scalable from manual R&D to automated production. The company works with science and bioengineering organizations to integrate 3D bioprinting into their research, manufacturing, and treatment methods. Brinter is active in over 10 countries and serves organizations such as Nanoform, as well as research organizations like VTT, BEST group at the University of Glasgow, Johannes Gutenberg University of Mainz, the University of Oulu, and the University of Helsinki.